查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830603

化合物管理市場（按最終用戶、化合物類型、應用和自動化程度分類）—2025-2032 年全球預測

Compound Management Market by End User, Compound Type, Application, Automation Level - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，複合管理市場將成長至 44.5 億美元，複合年成長率為 17.27%。

主要市場統計數據
基準年2024年 12.4億美元
預計2025年 14.5億美元
預測年份：2032年 44.5億美元
複合年成長率（%） 17.27%

簡明框架描述不斷發展的化合物管理格局，強調重塑實驗室工作流程的技術、材料和營運壓力

化合物管理處於高通量科學、精準處理和日益複雜的供應鏈動態的交匯點。自動化、樣品完整性監測和數位化庫存管理領域的最新技術進步正在重新定義科學研究和商業性研發領域對精度、速度和可追溯性的期望。同時，治療模式向生技藥品、細胞和基因療法的轉變也帶來了新的物料輸送要求，這對傳統平台提出了挑戰，並需要專門客製化的解決方案。

因此，領導者必須協調對穩健合規的化合物儲存的需求與提高吞吐量和降低營運風險的壓力。本介紹將重塑化合物管理的各種力量統一起來，明確價值創造的領域，並組裝組織領導者應優先考慮的策略問題。建立通用的基準，使決策者能夠更自信地評估技術投資、夥伴關係和流程重新設計，從而使化合物處理能力與更廣泛的科學和監管目標保持一致。

自動化、生技藥品複雜性和數據主導的互通性如何將化合物管理重新定義為一項策略性實驗室能力

在科技趨勢融合的推動下，化合物管理格局正經歷一場變革。自動化正在超越機械化，發展成為整合式工作流程，其中機器人、環境控制和實驗室資訊管理系統協同工作，形成一個整體。這種整合實現了可擴展的樣本通量，同時減少了人工接觸點和錯誤率。同時，複雜生技藥品、基因療法和細胞產品的興起，對儲存、處理和可追溯性提出了新的要求，而傳統的小分子專用系統無法滿足這些要求。

同時，以數據為中心的方法正在改變組織管理化合物庫存的方式。進階分析和預測性維護可以提高運作並減少試劑浪費，而數位審核追蹤則可以增強法規遵循。此外，儀器製造商和軟體供應商之間的合作正在加速實驗室採用模組化、可升級系統的步伐。總而言之，這些轉變意味著化合物管理不再是一項後勤部門功能，而是一項支援更快、更安全、更具成本效益的研究流程的策略能力。

營運和採購對關稅變化的反應正在重塑供應商策略、庫存實踐和國際實驗室合作

2025 年的關稅變化給採購、合約營運和跨境研究合作帶來了特殊壓力。某些檢測設備、耗材和化學品的進口關稅上調，促使許多組織重新評估其供應商組合併重新協商契約，以保持營運的連續性。因此，採購團隊正在與科學研究主管更緊密地合作，確定關鍵物資的優先儲備，考慮替代供應商，並對區域代理商進行認證，以減少單一來源的風險。

在營運層面，一些實驗室正在調整維護和校準計劃，以最佳化現有設備的生命週期，避免在進口成本上漲期間即時更換設備。此外，他們更重視關鍵物資的國內生產，並建立試劑和耗材的策略性庫存緩衝。由於海關分類和合規性檢查，國際合作的前置作業時間更長，行政負擔也更重。為此，研究機構正在加強供應鏈管治，增強需求預測實踐，並尋求在買方和供應商之間共用關稅風險的合約條款，以保持研究的連續性。

深度細分主導的洞察，揭示最終用戶、化合物類型、應用和自動化程度之間的不同需求，以指導策略性產品和服務的協調

細分洞察揭示了差異化需求和採用模式，這些需求和模式指南產品開發、服務模式和市場開發方法。從最終用戶的觀點，學術和研究機構通常優先考慮靈活性、成本效益以及與多樣化設備的開放式整合；而製藥公司則尋求檢驗的可擴展系統，該系統具有嚴格的合規能力和長期服務協議；生物技術公司通常尋求能夠適應計劃範圍快速變化的模組化解決方案；而受託研究機構專注於高水準和監管工作，以適應工程範圍快速變化的模組化解決方案；

小分子通常受益於成熟的高密度儲存和自動搜尋系統，而生技藥品則需要專門的溫度控制和污染預防。在生技藥品領域，細胞治療產品、基因治療產品、單株抗體、重組蛋白和疫苗各自具有獨特的處理和監管要求，這些要求會影響容器格式、低溫運輸通訊協定和檢驗途徑。基於應用的細分錶明，農業化學品和材料科學等使用案例與藥物研發活動具有不同的吞吐量和環境耐受性要求。在藥物研發領域，諸如命中化合物識別、先導化合物最佳化、臨床前研究和標靶驗證等不同的工作流程對採樣節奏、等分試樣大小和完整性監測需求有特定的要求。選擇全自動系統的組織會投資於端到端的數位化工作流程，並且需要更高的初始投資才能達到長期效率。同時，當靈活性、低資本支出或獨特的樣品類型阻礙了全自動系統時，手動和半自動化系統仍然很受歡迎。了解這些相互交叉的細分市場，可以幫助供應商和使用者根據實際營運需求調整解決方案的功能、服務水準和定價策略。

區域科學生態系統和法規環境如何影響全球市場的化合物管理重點、支援模型和自動化採用

區域動態決定了化合物管理投資、夥伴關係和營運彈性的優先順序。美洲集中了大型製藥研發中心和成熟的生物技術生態系統，推動了對高通量、檢驗的系統和服務模式的需求，以支持監管發展。該地區還擁有蓬勃發展的綜合服務和本地化支援網路售後市場，鼓勵供應商提供長期服務協議和客製化選項。歐洲、中東和非洲呈現出多元化的格局，跨國公司與國家研究機構和新興生物技術部門並肩作戰。歐洲部分地區的監管協調與其他地區針對特定區域的採購規則形成鮮明對比，這正在塑造自動化和先進庫存系統的採用曲線。平衡跨境合作與當地監管限制的需求，導致該地區對合規的模組化解決方案產生了濃厚的興趣。

亞太地區的特點是產能擴張迅速，對轉化和臨床研究投入巨大，並且生物技術新興企業需要靈活且可擴展的化合物管理解決方案。該地區的供應鏈覆蓋也促進了製造和零件採購機會，從而可以縮短某些設備的前置作業時間。在整個地區，人事費用、監管複雜性和基礎設施成熟度的差異會影響全自動、半自動化或手動方法之間的選擇，從而為提供差異化服務創造了機會，例如遠距離診斷、區域備件庫存和區域驗證支援。

競爭動態和夥伴關係趨勢揭示了硬體、軟體和服務整合以及以應用為中心的創新如何塑造供應商差異化和客戶維繫

競爭考察重點在於策略定位、夥伴關係模式以及日益凸顯競爭差異化的領域。市場領導若能將強大的硬體產品組合與擴充性的軟體平台和成熟的服務產品結合，最有可能贏得需要長期檢驗和保證運作的企業級專案。相反，新興供應商將透過提供模組化、可升級的架構來降低中型實驗室實現自動化的門檻，並透過開放API強調互通性，從而促進與實驗室資訊管理系統的整合，從而獲得發展動力。隨著企業尋求提供涵蓋安裝、檢驗、維護和資料管理的端到端價值提案，儀器製造商、軟體供應商和第三方服務機構之間的策略夥伴關係正變得越來越普遍。

此外，一些公司正在投資特定應用的解決方案，以滿足生技藥品、細胞和基因療法的獨特需求，例如溫控物流和污染控制創新。差異化服務也值得關注：能夠提供快速現場支援、透過物聯網感測器進行遠端預測性維護以及為內部技術人員提供客製化培訓的供應商往往能夠減少停機時間並增強客戶維繫。最後，那些透過節能儲存系統和減少消耗品的措施展現永續性承諾的公司，正在與尋求實現環境和管治目標的機構投資者產生共鳴。

為高階主管提供可行的策略重點，以增強其複合管理環境中的互通性、供應彈性和數據主導的營運

產業領導者應採取果斷行動，將化合物管理能力與科學策略和營運彈性結合。首先，高階主管在互通性，管治合格舉措試劑利用率，從而同時提高吞吐量並降低營運風險。

此外，領導者應透過情境規劃來評估其供應商和服務合約組合，其中應考慮區域採購差異和潛在的政策變化。投資員工培訓和內部驗證能力可以減少對外部服務供應商的依賴，並加快實驗時間。最後，永續性和合規性應被定位為策略要務。採用節能儲存技術，盡可能減少一次性塑膠的消費量，並記錄監管鏈，可以緩解長期成本壓力，並使組織與不斷變化的相關人員期望保持一致。

採用嚴格的混合方法，結合實務工作者訪談、技術文獻綜述和專家檢驗，得出實用的商業見解和策略建議

本執行摘要所依據的調查方法是將一手資料和二手資料結構化地結合起來，並經過專家檢驗以確保其有效性和實用性。一手資料包括對學術機構、生物技術、合約研究、政府機構和製藥公司的實驗室經理、採購主管和技術總監的訪談，以獲得第一手資料，了解他們的營運挑戰和採購行為。二手資料包括供應商技術文獻、監管指南文件、說明小分子和複雜生技藥品不斷變化的處理要求的同行評審出版物，以及關於自動化和資料整合最佳實踐的白皮書。

這些輸入資訊採用主題分析法進行綜合，以識別反覆出現的痛點、應用推動因素和價值槓桿。與經驗豐富的技術人員和供應鏈專業人員進行交叉檢驗，確保營運建議基於現實世界的限制和機會。我們謹慎地將敏感貢獻者資訊匿名化，所有結論均側重於定性趨勢和可操作的洞察，而非定量的市場估計，使領導者能夠將研究結果直接應用於技術選擇、流程重新設計和供應商談判。

全面、前瞻性的演示，解釋為什麼化合物管理是研發組織研究速度、樣品完整性和法規遵循的策略推動因素

總而言之，化合物管理已從後勤部門功能演變為策略功能，對研究速度、資料完整性和法規遵循有重大影響。自動化程度的提高、生技藥品、細胞和基因療法日益重要，以及數據驅動的維護和庫存管理日益重要，正在推動系統互通性、環境控制和服務可靠性的更高標準。積極在採購、科研營運和IT職能部門進行協作的組織將更有能力利用現代化合物管理系統帶來的生產力提升，並降低與供應鏈波動和監管審查相關的風險。

展望未來，決策者應將化合物管理視為其研究平台策略的重要組成部分，在必要時投資模組化、檢驗的系統，加強供應商和區域風險管理，並利用分析技術最佳化運作和試劑使用。這樣做將使實驗室和開發機構能夠提高通量，保護樣品完整性，並支持推動科學和商業性成功的轉化目標。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 透過人工智慧驅動的調度和預測路由整合，實現複合儲存搜尋工作流程的自動化
  • 採用機器人納升液體處理系統實現高密度化合物庫管理
  • 在分散的化合物存儲庫中實施基於區塊鏈的監管鏈追蹤
  • 引入支援物聯網的溫度和濕度感測器，用於即時化合物穩定性監測
  • 利用數位雙胞胎模擬最佳化冷凍庫除霜循環和化合物管理中的樣品完整性
  • 化學品管理設施向永續無溶劑清潔和低溫儲存方法過渡

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：化合物管理市場（依最終用戶分類）

  • 學術研究機構
  • 生技公司
  • 合約研究組織
  • 政府和監管機構
  • 製藥公司

9. 化合物管理市場（依化合物類型）

  • 生物製藥
    • 細胞治療產品
    • 基因治療產品
    • 單株抗體
    • 重組蛋白
    • 疫苗
  • 核苷酸
  • 胜肽
  • 小分子

第 10 章化合物管理市場：依應用

  • 殺蟲劑
  • 藥物研發
    • 命中識別
    • 先導藥物最適化
    • 臨床前研究
    • 目標檢驗
  • 材料科學
  • 特種化學品

第 11 章 複合管理市場（依自動化程度）

  • 全自動系統
  • 手動系統
  • 半自動系統

第12章化合物管理市場：按地區

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 化合物管理市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國化合物管理市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Tecan Group Ltd.
    • Hamilton Bonaduz AG
    • Brooks Automation, Inc.
    • Chemspeed Technologies GmbH
    • Hudson Robotics, Inc.
    • Analytik Jena AG
Product Code: MRR-436BDB26AFD9

The Compound Management Market is projected to grow by USD 4.45 billion at a CAGR of 17.27% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.24 billion
Estimated Year [2025] USD 1.45 billion
Forecast Year [2032] USD 4.45 billion
CAGR (%) 17.27%

A concise framing of the evolving compound management landscape emphasizing technological, material, and operational pressures reshaping laboratory workflows

The compound management landscape sits at the intersection of high-throughput science, precision handling, and increasingly complex supply chain dynamics. Recent technological advances in automation, sample integrity monitoring, and digital inventory control have redefined expectations for accuracy, speed, and traceability across research organizations and commercial R&D. At the same time, shifts in therapeutic modalities toward biologics and cell and gene therapies have introduced new material handling requirements that challenge legacy platforms and demand purpose-built solutions.

Consequently, leaders must reconcile the need for robust, compliant compound custody with pressures to increase throughput and lower operational risk. This introduction synthesizes the forces reshaping compound management, clarifies where value is being created, and frames the strategic questions organizational leaders should prioritize. By establishing a shared baseline, decision-makers can evaluate technology investments, partnerships, and process redesigns with greater confidence and align compound handling capabilities to broader scientific and regulatory objectives.

How automation, biologics complexity, and data-driven interoperability are redefining compound management as a strategic laboratory capability

The landscape for compound management is undergoing transformative shifts driven by converging technological and scientific trends. Automation is maturing beyond mechanization into integrated workflows where robotics, environmental controls, and laboratory information management systems operate as a synchronized whole. This integration reduces manual touchpoints and error rates while enabling scalable sample throughput, yet it also increases the importance of systems interoperability and vendor collaboration. Simultaneously, the rise of complex biologics, gene therapies, and cell-based products imposes new storage, handling, and traceability requirements that legacy small-molecule-focused systems were not designed to satisfy.

In parallel, data-centric approaches are changing how organizations manage compound inventories. Advanced analytics and predictive maintenance improve uptime and reduce reagent waste, and digital audit trails enhance regulatory readiness. Moreover, partnerships between instrument manufacturers and software providers are accelerating the pace at which laboratories can adopt modular, upgradeable systems. Taken together, these shifts mean that compound management is no longer a back-office function; it is a strategic capability that underpins faster, safer, and more cost-effective research pipelines.

Operational and procurement responses to tariff shifts that are reshaping supplier strategies, inventory practices, and international collaboration in laboratories

Tariff dynamics introduced in 2025 have created tangible pressures across procurement, contract operations, and cross-border research collaborations. Elevated duties on specific laboratory equipment, consumables, and chemical imports have prompted many organizations to re-evaluate supplier portfolios and renegotiate contracts to preserve continuity of operations. As a result, procurement teams are working more closely with scientific leads to prioritize critical items for stockpiling, explore alternative suppliers, and qualify regional distributors to mitigate single-source exposure.

At the operational level, some laboratories have adjusted maintenance and calibration schedules to optimize the lifecycle of existing instruments and avoid immediate capital replacement during periods of higher import costs. In addition, greater emphasis is being placed on localization of critical supplies and on building strategic inventory buffers for reagents and consumables. International collaborations face added administrative burdens as customs classifications and compliance checks have increased lead times. In response, institutions are strengthening supply chain governance, enhancing demand forecasting practices, and pursuing contractual terms that share tariff risk between buyers and suppliers to sustain research continuity.

Deep segmentation-driven insights that illuminate distinct requirements across end users, compound types, applications, and automation levels to guide strategic product and service alignment

Segmentation insights reveal differentiated needs and adoption patterns that should guide product development, service models, and go-to-market approaches. When viewed through the lens of end users, academic and research institutions typically prioritize flexibility, cost-effectiveness, and open integration with diverse instrument fleets, whereas pharmaceutical companies demand validated, scalable systems with rigorous compliance features and long-term service commitments. Biotech companies often seek modular solutions that can accommodate rapid pivots in project scope, while contract research organizations focus on high-throughput capacity and standardized workflows to serve multiple clients. Government and regulatory agencies emphasize chain-of-custody and long-term archival integrity for samples used in surveillance and public health research.

Analyzing compound type highlights further nuances: small molecules generally benefit from established, high-density storage and automated retrieval systems, while biologics require specialized temperature control and contamination prevention; within biologics, cell therapy products, gene therapy products, monoclonal antibodies, recombinant proteins, and vaccines each present unique handling and regulatory demands that influence container formats, cold chain protocols, and validation pathways. Application-based segmentation shows that use cases such as agrochemicals and material science have different throughput and environmental tolerance requirements compared with drug discovery activities; within drug discovery, discrete workflows like hit identification, lead optimization, preclinical research, and target validation impose specific sampling cadence, aliquot sizing, and integrity monitoring needs. Finally, automation level differentiates buyer readiness: organizations opting for fully automated systems invest in end-to-end digital workflows and higher upfront capital for long-term efficiency, while manual and semi-automated systems remain prevalent where flexibility, lower capital expenditure, or unique sample types preclude full automation. Understanding these intersecting segments enables vendors and users to align solution features, service levels, and pricing strategies to real operational requirements.

How regional scientific ecosystems and regulatory environments influence compound management priorities, support models, and adoption of automation across global markets

Regional dynamics shape how organizations prioritize investments, partnerships, and operational resilience in compound management. In the Americas, a concentration of large pharmaceutical R&D hubs and mature biotech ecosystems drives demand for high-throughput, validated systems and service models that support regulated development. This region also features a strong aftermarket for integration services and localized support networks, encouraging vendors to offer long-term service agreements and customization options. Europe, the Middle East & Africa presents a diverse landscape where multinationals operate alongside national research institutes and an emerging biotech sector; regulatory harmonization across parts of Europe contrasts with localized procurement rules elsewhere, shaping adoption curves for automation and advanced inventory systems. In this region, interest in compliance-ready, modular solutions is pronounced given the need to balance cross-border collaboration with local regulatory constraints.

Asia-Pacific remains characterized by rapid capacity expansion, significant investment in translational and clinical research, and energetic growth of biotech startups that often demand flexible, scalable compound management solutions. The supply chain footprint in this region also fosters manufacturing and component sourcing opportunities, which can lower lead times for certain equipment. Across all regions, variations in labor costs, regulatory complexity, and infrastructure maturity influence the choice between fully automated and semi-automated or manual approaches, and they create opportunities for differentiated service offerings such as remote diagnostics, regional spare parts inventories, and localized validation support.

Competitive dynamics and partnership trends revealing how hardware-software-service integration and application-focused innovation are shaping vendor differentiation and customer retention

Key company insights focus on strategic positioning, partnership models, and the areas where competitive differentiation is emerging. Market leaders that pair robust hardware portfolios with scalable software platforms and proven service delivery are best positioned to capture enterprise-level programs requiring long-term validation and uptime guarantees. Conversely, emerging vendors find traction by offering modular, upgradeable architectures that lower the barrier to automation for midsized laboratories and by emphasizing interoperability through open APIs that facilitate integration with laboratory information management systems. Strategic partnerships between instrument manufacturers, software providers, and third-party service organizations are increasingly common as companies seek to deliver end-to-end value propositions covering installation, validation, maintenance, and data management.

Additionally, some firms are investing in application-specific solutions that address the unique demands of biologics and cell and gene therapies, including temperature-controlled logistics and contamination control innovations. Service differentiation is also notable: providers that can offer rapid on-site support, predictive maintenance remotely enabled by IoT sensors, and tailored training for in-house technical staff tend to reduce downtime and build stronger customer retention. Finally, companies that demonstrate a commitment to sustainability through energy-efficient storage systems and consumable reduction initiatives are resonating with institutional buyers seeking to meet environmental and governance objectives.

Actionable strategic priorities for executives to strengthen interoperability, supply resilience, and data-driven operations in compound management environments

Industry leaders should take decisive actions to align compound management capabilities with scientific strategy and operational resilience. First, executives should prioritize interoperability and modularity when evaluating new equipment, ensuring that investments can be scaled or repurposed as scientific priorities change. Second, cross-functional governance structures that include procurement, scientific operations, quality, and IT should be established to streamline supplier qualification, manage tariff and supply chain risk, and enforce data integrity standards. Third, organizations should pilot data-rich initiatives that use analytics and IoT-enabled diagnostics to reduce unplanned downtime and optimize reagent utilization, thereby simultaneously improving throughput and lowering operational risk.

Moreover, leaders ought to assess their portfolio of suppliers and service agreements through scenario planning that accounts for regional sourcing variability and potential policy shifts. Investing in staff training and in-house validation capabilities will reduce dependency on external service providers and accelerate time-to-experiment. Finally, sustainability and compliance should be elevated as strategic imperatives; adopting energy-efficient storage technologies, reducing single-use plastic consumption where feasible, and documenting chain-of-custody practices will both reduce cost pressure over time and align the organization with evolving stakeholder expectations.

A rigorous mixed-methods approach combining practitioner interviews, technical literature review, and expert validation to derive practical operational insights and strategic recommendations

The research methodology underpinning this executive summary combined a structured review of primary and secondary inputs with expert validation to ensure relevance and practical applicability. Primary sources included interviews with laboratory managers, procurement heads, and technical leads across academic, biotech, contract research, government, and pharmaceutical organizations to capture firsthand operational challenges and procurement behaviors. Secondary inputs encompassed vendor technical literature, regulatory guidance documents, and peer-reviewed publications that describe evolving handling requirements for small molecules and complex biologics, as well as white papers on automation and data integration best practices.

These inputs were synthesized using a thematic analysis approach to identify recurring pain points, adoption enablers, and value levers. Cross-validation with experienced technologists and supply chain specialists ensured that operational recommendations were grounded in real-world constraints and opportunities. Care was taken to anonymize sensitive contributor information, and all conclusions emphasize qualitative trends and actionable insights rather than quantitative market estimates, enabling leaders to apply findings directly to technology selection, process redesign, and vendor negotiations.

A forward-looking synthesis explaining why compound management is now a strategic enabler of research velocity, sample integrity, and regulatory readiness for R&D organizations

In conclusion, compound management has evolved from a largely transactional back-office function to a strategic capability that materially influences research velocity, data integrity, and regulatory readiness. Advancements in automation, the growing prominence of biologics and cell and gene therapies, and increasing emphasis on data-driven maintenance and inventory control are converging to raise the bar for system interoperability, environmental controls, and service reliability. Organizations that proactively align procurement, scientific operations, and IT functions will be better positioned to capture the productivity gains offered by modern compound management systems and to mitigate risks associated with supply chain volatility and regulatory scrutiny.

Moving forward, decision-makers should treat compound management as an integral component of their research platform strategy-investing in modular, validated systems where appropriate, strengthening supplier and regional risk management, and leveraging analytics to optimize uptime and reagent use. By doing so, laboratories and development organizations can improve throughput, safeguard sample integrity, and support the translational goals that drive scientific and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven scheduling and predictive routing for automated compound storage retrieval workflows
  • 5.2. Adoption of robotic nanoliter liquid handling systems enabling high-density compound library management
  • 5.3. Implementation of blockchain-enabled chain of custody tracking across decentralized compound repositories
  • 5.4. Deployment of IoT-enabled temperature and humidity sensors for real-time compound stability monitoring
  • 5.5. Utilization of digital twin simulations to optimize freezer defrost cycles and sample integrity in compound management
  • 5.6. Transition to sustainable solvent-free cleaning and cryogenic storage methods in compound management facilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Compound Management Market, by End User

  • 8.1. Academic And Research Institutions
  • 8.2. Biotech Companies
  • 8.3. Contract Research Organizations
  • 8.4. Government And Regulatory Agencies
  • 8.5. Pharmaceutical Companies

9. Compound Management Market, by Compound Type

  • 9.1. Biologics
    • 9.1.1. Cell Therapy Products
    • 9.1.2. Gene Therapy Products
    • 9.1.3. Monoclonal Antibodies
    • 9.1.4. Recombinant Proteins
    • 9.1.5. Vaccines
  • 9.2. Nucleotides
  • 9.3. Peptides
  • 9.4. Small Molecules

10. Compound Management Market, by Application

  • 10.1. Agrochemicals
  • 10.2. Drug Discovery
    • 10.2.1. Hit Identification
    • 10.2.2. Lead Optimization
    • 10.2.3. Preclinical Research
    • 10.2.4. Target Validation
  • 10.3. Material Science
  • 10.4. Specialty Chemicals

11. Compound Management Market, by Automation Level

  • 11.1. Fully Automated Systems
  • 11.2. Manual Systems
  • 11.3. Semi Automated Systems

12. Compound Management Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Compound Management Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Compound Management Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Thermo Fisher Scientific Inc.
    • 15.3.2. Danaher Corporation
    • 15.3.3. Agilent Technologies, Inc.
    • 15.3.4. PerkinElmer, Inc.
    • 15.3.5. Tecan Group Ltd.
    • 15.3.6. Hamilton Bonaduz AG
    • 15.3.7. Brooks Automation, Inc.
    • 15.3.8. Chemspeed Technologies GmbH
    • 15.3.9. Hudson Robotics, Inc.
    • 15.3.10. Analytik Jena AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. COMPOUND MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. COMPOUND MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COMPOUND MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GOVERNMENT AND REGULATORY AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY CELL THERAPY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GENE THERAPY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AGROCHEMICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY HIT IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MATERIAL SCIENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SPECIALTY CHEMICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 297. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GCC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GCC COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. GCC COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. GCC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 304. GCC COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 305. GCC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. GCC COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. GCC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 308. GCC COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 309. GCC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 310. GCC COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY COMPOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY DRUG DISCOVERY, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION COMPOUND MANAGEMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION